合法博彩网站

During its March plenary session, 合法博彩网站 is due to debate a European Commission statement on the Critical Medicines Act. The Commission is expected to adopt the proposed regulation 鈥� which aims to address the severe shortages of medicines, reduce dependencies relating to critical medicines and ingredients, and ensure the supply of affordable medicines 鈥� on 11 March 2025.

Good health and well-being is a key indicator and a precondition for sustainable development, allowing people to enjoy fulfilling lives, receive education and be productive members of society. In contrast, the burden of disease has high economic, social and individual costs. Therefore, achieving the highest attainable level of health is of interest for all. However, amidst the COVID-19 pandemic and ongoing crises, progress towards United Nations Sustainable Development Goal (UN SDG) 3 ('ensure healthy ...

This in-depth analysis (IDA) provides a broad overview over the emerging challenges connected with disinformation in the area of health, the way it spreads and the damage it causes. The report further highlights proposed or implemented measures at various levels to address health-related disinformation, accompanied by recommendations aimed at mitigating its impact on the well-being of Europeans.

There are around 36 million patients suffering from rare diseases in the EU. This in-depth analysis gives an overview of European actions for rare diseases to date and identifies opportunities and gaps for further EU level actions to improve diagnosis, care, and treatment for rare diseases. This document was provided by the Policy Department for Economic, Scientific and Quality of Life Policies at the request of the Committee on Public Health (SANT).

On 10 April 2024, the European 合法博彩网站 adopted its position at first reading on two European Commission proposals to revise the EU's pharmaceutical legislation. The revision seeks to enhance the security of supply of medicines, making them more available, accessible and affordable across EU countries, while supporting the attractiveness of the EU pharmaceutical industry by fostering research and innovation. The 'pharmaceutical package' includes proposals for a new directive and a new regulation ...

The COVID-19 pandemic shone a light on the growing importance of digital health technologies, both to enable remote medical care and to facilitate the health response from international, national and local authorities. The European Commission's May 2022 proposal for a regulation on a European health data space aims to improve individuals' access to and control over their electronic personal data (primary use), while facilitating data re-use for the good of society across the EU (secondary use). The ...

In October 2022, under the European Green Deal, the European Commission tabled a proposal for a recast of the Urban Wastewater Treatment Directive. Dating back to 1991, and instrumental to the achievement of European Union water policy objectives, the directive needs to be updated and adapted to new challenges and realities. The recast proposal would introduce new obligations to do more to control pollution due to rainwater, impose stricter standards for nutrient removal and require advanced treatment ...

In December 2022, the European Commission proposed a revision of the Regulation on the classification, labelling and packaging of substances and mixtures, one of the two cornerstones of the EU's framework regulating chemicals. The revision, announced in the EU chemicals strategy for sustainability, notably seeks to identify and classify hazardous chemicals more comprehensively; improve communication on chemical hazards and the notification of relevant information to poison centres for emergency health ...

The European Union stepped up its action in the area of health 鈥� a shared competence between the EU and its Member States 鈥� in response to the COVID 19 pandemic. Yet, the EU lacks a joint health policy that recognises health as a public good. This study investigates three areas where there is high added-value potential from a joint EU health policy: research and development; the availability of prescription medicines; and preventive healthcare. EU action in these areas could generate benefits for ...

The recent stunning geopolitical events have prompted a wave of initiatives and proposals that seek to endow the European Union with responsibilities currently exercised at the national level. The present study uses examines which proposals match the principles of fiscal federalism to be considered properly as European public goods. This document was provided/prepared by the Economic Governance and EMU Scrutiny Unit at the request of the ECON Committee.